Plandaí Biotechnology, Inc. (OTCBB: PLPL) Chief Executive Officer, Roger Duffield, today announced that Dr. Tom Matula has accepted the position of Chairman of the Scientific Board for Plandaí Biotechnology, Inc., effective immediately.
Dr. Matula is a world-renowned scientist and entrepreneur with expertise in medical and industrial applications of ultrasound. He is the author of over 40 peer-reviewed publications and has several patents in the medical devices landscape. Dr. Matula is a past winner of the Department of Defense Young Scientist Award and was also awarded the Presidential Early Career Award, the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their careers. He has advised members of congress on energy issues, and helps organize panels on technology transfer out of universities.
Dr. Matula received his PhD. in Physics from Washington State University. He currently serves as Affiliate Associate Professor, Bioengineering and Electrical Engineering with the University of Washington, is the Director of the Center for Industrial and Medical Ultrasound and the Director of the Center for Ultrasound-based Molecular Imaging and Therapy, both with the University of Washington. Dr. Matula also serves as Principal Physicist with the Applied Physics Laboratory at the University of Washington.
Dr. Matula is a co-inventor of Plandaí Biotechnology’s proprietary technology that extracts a high level of bio-available compounds from organic matter including green tea leaves and most other organic materials. Various tests have been conducted over the past ten years using this technology that generates functional chemical compounds possessing nutritive properties that act effectively as preventive agents in the healthcare field. Polyphenols from green tea are an excellent source of antioxidant and anti-carcinogenic substances. Dr.Matula has been instrumental in bringing this technology to market through Plandaí Biotechnology.
Mr. Duffield commented, “Plandaí is delighted that Dr. Matula has accepted the chair position as we have been working together on the science behind our company for over 10 years. As a scientist, he brings a wealth of experience and insight as we transition from research into market-ready products. Plandaí Biotechnology intends to continue adding highly qualified and experienced professionals to our Scientific Advisory Board. Dr. Matula’s leadership as the Chairman of our Scientific Board demonstrates the acceptance within the scientific community of our technology.”
Additional information on Dr. Matula’s background can be found at: http://www.apl.washington.edu/people/profile.php?last=Matula&first=Tom.
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc., through its recent acquisition of Global Energy Solutions, Ltd. and its subsidiaries, focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principal holdings consist of land, farms and infrastructure in South Africa.
Source: Marketwire
“Be fearful when others are greedy, and be greedy when others are fearful.” – Warren Buffett
If you really want to make some considerable profits from the stock market, it is possible to make a considerable amount of money on penny stock trading. When you find the right penny stock to buy, knowing when to buy and sell is the second most important tool to maximizing your profits.
Being technical, analytical or just flat-out greedy when trading penny stocks is the easiest way to limit profits and, sometimes, even lose your entire investment. You need to have a strong and strict strategy to achieve your goal of maximizing profits while minimizing risks in penny stocks.
Listed below are a few of the many points each and every penny stock investor needs to discover.
- Do your own research.
- Trade Responsibly.
- Verify everything.
- Move Fast or Get Left Behind.
- Do not use market orders to enter a position, use limit orders.
- Have a System That fits You.
- If a Stock Gaps Open, Look for Pullbacks to Enter.
- Plan a Trade and Trade a Plan.
- Always use stop loss orders to protect yourself.
- Positive Self- Belief.
- Keep trading as Part of a Balanced life.
- If a stock breaks below our alert price GET OUT. Do not wait.
- View Trading as a Score in Points and Not In Money:
- Always take your profits whenever you can. Do Not Be Greedy.
- Work Hard at Learning How to Trade Properly and Keep Working.
- Do something to make someone else’s life better today.
About AimHighProfits.com
AimHighProfits.com strives to provide you with the hottest stock alerts in the market in Real-Time. We focus on stocks that trade for $5 per share or less, some as little as a few pennies with upside potential.
Our goal is committed to producing and publishing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions and to inform you of the best stocks in the market before they move. Our focus is primarily on OTC stocks in the stock market today which have traditionally been ignored by Wall Street.
We have particular expertise with internet stocks, gold stocks, renewable energy stocks, biotech stocks, oil stocks and green energy stocks. There are many hot penny stock opportunities present in the OTC market every day and we seek to exploit these hot stock gains for our members before the average daytrader is made aware of them.
Aim High Profits Disclaimer
This is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.
AimHighProfits.com is a wholly-owned subsidiary of Kelevra Media Innovation.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision.
Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
For a complete explanation, please visit our disclaimer page.
ShareJAN
